Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

Lead Discovery Strategies for Identification of Chlamydia pneumoniae Inhibitors.

Hanski L, Vuorela P.

Microorganisms. 2016 Nov 28;4(4). pii: E43. Review.

2.

Natural Products for the Treatment of Chlamydiaceae Infections.

Brown MA, Potroz MG, Teh SW, Cho NJ.

Microorganisms. 2016 Oct 16;4(4). pii: E39. Review.

3.

Evolution to a chronic disease niche correlates with increased sensitivity to tryptophan availability for the obligate intracellular bacterium Chlamydia pneumoniae.

Huston WM, Barker CJ, Chacko A, Timms P.

J Bacteriol. 2014 Jun;196(11):1915-24. doi: 10.1128/JB.01476-14. Epub 2014 Mar 28. Review.

4.

Laboratory diagnosis of Chlamydia pneumoniae infections.

Peeling RW.

Can J Infect Dis. 1995 Jul;6(4):198-203.

6.

A population based seroepidemiological survey of Chlamydia pneumoniae infections in schoolchildren.

Dal Molin G, Longo B, Not T, Poli A, Campello C.

J Clin Pathol. 2005 Jun;58(6):617-20.

7.

Prevalence and persistence of Chlamydia pneumoniae antibodies in healthy laboratory personnel in Finland.

Paldanius M, Bloigu A, Alho M, Leinonen M, Saikku P.

Clin Diagn Lab Immunol. 2005 May;12(5):654-9.

8.

BTS Guidelines for the Management of Community Acquired Pneumonia in Adults.

British Thoracic Society Standards of Care Committee.

Thorax. 2001 Dec;56 Suppl 4:IV1-64. No abstract available.

10.

Molecular diagnosis of Chlamydia pneumoniae infection.

Boman J, Gaydos CA, Quinn TC.

J Clin Microbiol. 1999 Dec;37(12):3791-9. Review. No abstract available.

11.

Identification of two novel genes encoding 97- to 99-kilodalton outer membrane proteins of Chlamydia pneumoniae.

Knudsen K, Madsen AS, Mygind P, Christiansen G, Birkelund S.

Infect Immun. 1999 Jan;67(1):375-83.

12.

Prevalence of specific antibodies to Chlamydia pneumoniae in Korea.

Choi TY, Kim DA, Kim SK, Kang JO, Park SS, Jung SR.

J Clin Microbiol. 1998 Nov;36(11):3426-8.

13.
14.

Chlamydia pneumoniae and asthma.

Cook PJ, Davies P, Tunnicliffe W, Ayres JG, Honeybourne D, Wise R.

Thorax. 1998 Apr;53(4):254-9.

16.

Chlamydia pneumoniae (TWAR).

Kuo CC, Jackson LA, Campbell LA, Grayston JT.

Clin Microbiol Rev. 1995 Oct;8(4):451-61. Review.

17.

Reactivation of Chlamydia pneumoniae infection in mice by cortisone treatment.

Laitinen K, Laurila AL, Leinonen M, Saikku P.

Infect Immun. 1996 Apr;64(4):1488-90.

18.

Cell-mediated immunity to Chlamydia pneumoniae measured as lymphocyte blast transformation in vitro.

Surcel HM, Syrjälä H, Leinonen M, Saikku P, Herva E.

Infect Immun. 1993 May;61(5):2196-9.

19.

The epidemic cycle of Chlamydia pneumoniae infection in eastern Finland, 1972-1987.

Karvonen M, Tuomilehto J, Pitkäniemi J, Saikku P.

Epidemiol Infect. 1993 Apr;110(2):349-60. Erratum in: Epidemiol Infect 1993 Dec;111(3):567.

20.

Selective translocation of annexins during intracellular redistribution of Chlamydia trachomatis in HeLa and McCoy cells.

Majeed M, Ernst JD, Magnusson KE, Kihlström E, Stendahl O.

Infect Immun. 1994 Jan;62(1):126-34.

Supplemental Content

Support Center